New cyclopentaquinoline and 3,5-dichlorobenzoic acid hybrids with neuroprotection against oxidative stress for the treatment of Alzheimer’s disease

References

• Padurariu M, Ciobica A, Lefter R, Serban IL, Stefanescu C, Chirita R. The oxidative stress hypothesis in Alzheimer’s disease. Psychiatr Danub. 2013;25(4):401–409.
   PubMed Web of Science ®Google Scholar
• Soto C. Plaque busters: strategies to inhibit amyloid formation in Alzheimer’s disease. Mol Med Today. 1999;5(8):343–350.
   PubMedGoogle Scholar
• Kubis AM, Janusz M. Alzheimer’s disease: new prospects in therapy and applied experimental models. Postepy Hig Med Dosw. 2008;62(:372–392.
   Web of Science ®Google Scholar
• Chen SY, Chen Y, Li YP, Chen SH, Tan JH, Ou TM, Gu LQ, Huang ZS. Design, synthesis, and biological evaluation of curcumin analogues as multifunctional agents for the treatment of Alzheimer’s disease. Bioorg Med Chem. 2011;19(18):5596–5604.
   PubMed Web of Science ®Google Scholar
• Silva D, Chioua M, Samadi A, Agostinho P, Garcao P, Lajarin-Cuesta R, de los Rios C, Iriepa I, Moraleda I, Gonzalez-Lafuente L, et al. Synthesis, pharmacological assessment, and molecular modeling of acetylcholinesterase/butyrylcholinesterase inhibitors: effect against amyloid-beta-induced neurotoxicity. ACS Chem Neurosci. 2013;4(4):547–565.
   PubMed Web of Science ®Google Scholar
• Mikiciuk-Olasik E, Szymański P, Zurek E. Diagnostics and therapy of Alzheimer’s disease. Indian J Exp Biol. 2007;45(4):315–325.
   PubMed Web of Science ®Google Scholar
• Li SY, Wang XB, Xie SS, Jiang N, Wang KDG, Yao HQ, Sun HB, Kong LY. Multifunctional tacrine flavonoid hybrids with cholinergic, beta-amyloid-reducing, and metal chelating properties for the treatment of Alzheimer’s disease. Eur J Med Chem. 2013;69(:632–646.
   PubMed Web of Science ®Google Scholar
• Zhao Y, Zhao BL. Oxidative stress and the pathogenesis of Alzheimer’s disease. Oxid Med Cell Longev. 2013;2013(10):316523.
   PubMedGoogle Scholar
• Olsson F, Schmidt S, Althoff V, Munter LM, Jin SB, Rosqvist S, Lendahl U, Multhaup G, Lundkvist J. Characterization of intermediate steps in amyloid beta (a beta) production under near-native conditions. J Biol Chem. 2014;289(3):1540–1550.
   PubMed Web of Science ®Google Scholar
• Brion JP, Couck AM, Passareiro E, Flament-Durand J. Neurofibrillary tangles of Alzheimer’s disease: an immunohistochemical study. J Submicrosc Cytol. 1985;17(1):89–96.
   PubMedGoogle Scholar
• Weingarten MD, Lockwood AH, Hwo SY, Kirschner MW. A protein factor essential for microtubule assembly. Proc Natl Acad Sci U S A. 1975;72(5):1858–1862.
   PubMed Web of Science ®Google Scholar
• Ramachandran G, Udgaonkar JB. Mechanistic studies unravel the complexity inherent in tau aggregation leading to Alzheimer’s disease and the tauopathies. Biochemistry. 2013;52(24):4107–4126.
   PubMed Web of Science ®Google Scholar
• Morris M, Maeda S, Vossel K, Mucke L. The many faces of tau. Neuron. 2011;70(3):410–426.
   PubMed Web of Science ®Google Scholar
• Contestabile A. The history of the cholinergic hypothesis. Behav Brain Res. 2011;221(2):334–340.
   PubMed Web of Science ®Google Scholar
• Mohamed T, Rao PPN. Alzheimer’s disease: emerging trends in small molecule therapies. Curr Med Chem. 2011;18(28):4299–4320.
   PubMed Web of Science ®Google Scholar
• Perl DP. Neuropathology of Alzheimer’s disease. Mt Sinai J Med. 2010;77(1):32–42.
   PubMedGoogle Scholar
• Reid GA, Darvesh S. Butyrylcholinesterase-knockout reduces brain deposition of fibrillar beta-amyloid in an Alzheimer mouse model. Neuroscience. 2015;298(:424–435.
   PubMed Web of Science ®Google Scholar
• Chen X, Wehle S, Kuzmanovic N, Merget B, Holzgrabe U, Konig B, Sotriffer CA, Decker M. Acetylcholinesterase inhibitors with photoswitchable inhibition of beta-amyloid aggregation. ACS Chem Neurosci. 2014;5(5):377–389.
   PubMed Web of Science ®Google Scholar
• Meng Q, Ru JH, Zhang GL, Shen C, Schmitmeier S, Bader A. Re-evaluation of tacrine hepatotoxicity using gel entrapped hepatocytes. Toxicol Lett. 2007;168(2):140–147.
   PubMed Web of Science ®Google Scholar
• Wu WY, Dai YC, Li NG, Dong ZX, Gu T, Shi ZH, Xue X, Tang YP, Duan JA. Novel multitarget-directed tacrine derivatives as potential candidates for the treatment of Alzheimer’s disease. J Enzyme Inhib Med Chem. 2017;32(1):572–587.
   PubMed Web of Science ®Google Scholar
• Morphy R, Kay C, Rankovic Z. From magic bullets to designed multiple ligands. Drug Discov Today. 2004;9(15):641–651.
   PubMed Web of Science ®Google Scholar
• Spilovska K, Korabecny J, Nepovimova E, Dolezal R, Mezeiova E, Soukup O, Kuca K. Multitarget tacrine hybrids with neuroprotective properties to confront Alzheimer’s disease. Curr Top Med Chem. 2017;17(9):1006–1026.
   PubMed Web of Science ®Google Scholar
• Bajda M, Jończyk J, Malawska B, Czarnecka K, Girek M, Olszewska P, Sikora J, Mikiciuk-Olasik E, Skibiński R, Gumieniczek A, et al. Synthesis, biological evaluation and molecular modeling of new tetrahydroacridine derivatives as potential multifunctional agents for the treatment of Alzheimer’s disease. Bioorg Med Chem. 2015;23(17):5610–5618.
   PubMed Web of Science ®Google Scholar
• Czarnecka K, Szymański P, Girek M, Mikiciuk-Olasik E, Skibiński R, Kabziński J, Majsterek I, Malawska B, Jończyk J, Bajda M. Tetrahydroacridine derivatives with fluorobenzoic acid moiety as multifunctional agents for Alzheimer’s disease treatment. Bioorg Chem. 2017;72(:315–322.
   PubMed Web of Science ®Google Scholar
• Skibiński R, Czarnecka K, Girek M, Bilichowski I, Chufarova N, Mikiciuk-Olasik E, Szymański P. Novel tetrahydroacridine derivatives with iodobenzoic acid moiety as multifunctional acetylcholinesterase inhibitors. Chem Biol Drug Des. 2018;91(2):505–518.
   PubMed Web of Science ®Google Scholar
• Souza MTD, Almeida J, Araujo AAD, Duarte MC, Gelain DP, Moreira JCF, dos Santos MRV, Quintans LJ. Structure-activity relationship of terpenes with anti-inflammatory profile – a systematic review. Basic Clin Pharmacol Toxicol. 2014;115(3):244–256.
   PubMed Web of Science ®Google Scholar
• Salvamani S, Gunasekaran B, Shukor MY, Shaharuddin NA, Sabullah MK, Ahmad SA. Anti-HMG-CoA reductase, antioxidant, and anti-inflammatory activities of Amaranthus viridis leaf extract as a potential treatment for hypercholesterolemia. Evid Based Complement Altern Med. 2016;2016:1–10.
   Web of Science ®Google Scholar
• Causier B, Davies B. Analysing protein-protein interactions with the yeast two-hybrid system. Plant Mol Biol. 2002;50(6):855–870.
   PubMed Web of Science ®Google Scholar
• Hamdi A, Colas P. Yeast two-hybrid methods and their applications in drug discovery. Trends Pharmacol Sci. 2012;33(2):109–118.
   PubMed Web of Science ®Google Scholar
• Baker K, Sengupta D, Salazar-Jimenez G, Cornish VW. An optimized dexamethasone-methotrexate yeast 3-hybrid system for high-throughput screening of small molecule-protein interactions. Anal Biochem. 2003;315(1):134–137.
   PubMed Web of Science ®Google Scholar
• Cottier S, Monig T, Wang ZM, Svoboda J, Boland W, Kaiser M, Kombrink E. The yeast three-hybrid system as an experimental platform to identify proteins interacting with small signaling molecules in plant cells: potential and limitations. Front Plant Sci. 2011;2:101.
   PubMed Web of Science ®Google Scholar
• Henthorn DC, Jaxa-Chamiec AA, Meldrum E. A GAL4-based yeast three-hybrid system for the identification of small molecule-target protein interactions. Biochem Pharmacol. 2002;63(9):1619–1628.
   PubMed Web of Science ®Google Scholar
• Licitra EJ, Liu JO. A three-hybrid system for detecting small ligand-protein receptor interactions. Proc Natl Acad Sci U S A. 1996;93(23):12817–12821.
   PubMed Web of Science ®Google Scholar
• Jabir NR, Rehman MT, Tabrez S, Alserihi RF, AlAjmi MF, Khan MS, Husain FM, Ahmed BA. Identification of butyrylcholinesterase and monoamine oxidase b targeted ligands and their putative application in Alzheimer’s treatment: A computational strategy. Curr Pharm Des. 2021;27(20):2425–2434.
   PubMed Web of Science ®Google Scholar
• Jabir NR, Shakil S, Tabrez S, Khan MS, Rehman MT, Ahmed BA. In silico screening of glycogen synthase kinase-3 beta targeted ligands against acetylcholinesterase and its probable relevance to Alzheimer’s disease. J Biomol Struct Dyn. 2021;39(14):5083–5092.
   PubMed Web of Science ®Google Scholar
• Czarnecka K, Girek M, Wójtowicz P, Kręcisz P, Skibiński R, Jończyk J, Łątka K, Bajda M, Walczak A, Galita G, et al. New tetrahydroacridine hybrids with dichlorobenzoic acid moiety demonstrating multifunctional potential for the treatment of Alzheimer’s disease. IJMS. 2020;21(11):3765.
   Google Scholar
• Szymanski P, Markowicz M, Bajda M, Malawska B, Mikiciuk-Olasik E. Synthesis and biological activity of new 2,3-dihydro-1h-cyclopenta b quinoline derivatives as acetylcholinesterase inhibitors. LDDD. 2012;9(7):645–654.
   Google Scholar
• Ellman GL, Courtney KD, Andres V, Feather-Stone RM. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol. 1961;7(2):88–95.
   PubMed Web of Science ®Google Scholar
• Czarnecka K, Girek M, Kręcisz P, Skibiński R, Łątka K, Jończyk J, Bajda M, Kabziński J, Majsterek I, Szymczyk P, et al. Discovery of new cyclopentaquinoline analogues as multifunctional agents for the treatment of Alzheimer’s disease. IJMS. 2019;20(3):498.
   Google Scholar
• Plumb JA. Cell sensitivity assays. In: Brown R, Böger-Brown U, editors. Cytotoxic drug resistance mechanisms. Totowa (NJ): Humana Press; 1999.
   Google Scholar
• González-Muñoz GC, Arce MP, López B, Pérez C, Romero A, del Barrio L, Martín-de-Saavedra MD, Egea J, León R, Villarroya M, et al. N-acylaminophenothiazines: neuroprotective agents displaying multifunctional activities for a potential treatment of Alzheimer’s disease. Eur J Med Chem. 2011;46(6):2224–2235.
   PubMed Web of Science ®Google Scholar
• Romero A, Egea J, González-Muñoz GC, Martín de Saavedra MD, del Barrio L, Rodríguez-Franco MI, Conde S, López MG, Villarroya M, de los Ríos C. ITH12410/SC058: a new neuroprotective compound with potential in the treatment of Alzheimer’s disease. ACS Chem Neurosci. 2014;5(9):770–775.
   PubMed Web of Science ®Google Scholar
• United States Pharmacopeial Convention. USP XXII-NF XVII. Rockville (MD): United States Pharmacopeial Convention, Inc.
   Google Scholar
• Piwowarski JP, Kiss AK, Kozłowska-Wojciechowska M. Anti-hyaluronidase and anti-elastase activity screening of tannin-rich plant materials used in traditional polish medicine for external treatment of diseases with inflammatory background. J Ethnopharmacol. 2011;137(1):937–941.
   PubMed Web of Science ®Google Scholar
• Michel P, Owczarek A, Matczak M, Kosno M, Szymański P, Mikiciuk-Olasik E, Kilanowicz A, Wesołowski W, Olszewska M. Metabolite profiling of eastern teaberry (Gaultheria procumbens L.) lipophilic leaf extracts with hyaluronidase and lipoxygenase inhibitory activity. Molecules. 2017;22(3):412.
   PubMed Web of Science ®Google Scholar
• Mao F, Li JH, Wei H, Huang L, Li XS. Tacrine-propargylamine derivatives with improved acetylcholinesterase inhibitory activity and lower hepatotoxicity as a potential lead compound for the treatment of Alzheimer’s disease. J Enzyme Inhib Med Chem. 2015;30(6):995–1001.
   PubMed Web of Science ®Google Scholar
• Chen XY, Zenger K, Lupp A, Kling B, Heilmann J, Fleck C, Kraus B, Decker M. Tacrine-silibinin codrug shows neuro- and hepato protective effects in vitro and pro-cognitive and hepatoprotective effects in vivo. J Med Chem. 2012;55(11):5231–5242.
   PubMed Web of Science ®Google Scholar
• OECD. No. 432: acute oral toxicity – acute toxic class method. OECD guidelines for the testing of chemicals. Paris: OECD; 2002.
   Google Scholar
• Espargaro A, Ginex T, Vadell MD, Busquets MA, Estelrich J, Munoz-Torrero D, Luque FJ, Sabate R. Combined in vitro cell-based/in silico screening of naturally occurring flavonoids and phenolic compounds as potential anti-Alzheimer drugs. J Nat Prod. 2017;80(2):278–289.
   PubMed Web of Science ®Google Scholar
• Pouplana S, Espargaro A, Galdeano C, Viayna E, Sola I, Ventura S, Munoz-Torrero D, Sabate R. Thioflavin-S staining of bacterial inclusion bodies for the fast, simple, and inexpensive screening of amyloid aggregation inhibitors. Curr Med Chem. 2014;21(9):1152–1159.
   PubMed Web of Science ®Google Scholar
• Espargaro A, Medina A, Di Pietro O, Munoz-Torrero D, Sabate R. Ultra rapid in vivo screening for anti-Alzheimer anti-amyloid drugs. Sci Rep. 2016;6(8):23349.
   PubMedGoogle Scholar
• Espargaro A, Pont C, Gamez P, Munoz-Torrero D, Sabate R. Amyloid pan-inhibitors: one family of compounds to cope with all conformational diseases. ACS Chem Neurosci. 2019;10(3):1311–1317.
   PubMed Web of Science ®Google Scholar
• Hansch C, Leo A, Hoekman D. Exploring QSAR: hydrophobic, electronic, and steric constants. Washington (DC): American Chemical Society; 1995.
   Google Scholar
• Sangster J. Octanol-water partition coefficients: fundamentals and physical chemistry. Wiley series in solutions chemistry. New York: Wiley; 1997.
   Google Scholar
• Perrin DD. Dissociation constants of organic bases in aqueous solution. IUPAC chemical data series: Supplement 1972. London: Butterworths; 1972.
   Google Scholar
• O'Neil MJ. The Merck index: an encyclopedia of chemicals, drugs, and biologicals. 14th ed. Whitehouse Station (NJ): Merck and Co., Inc.; 2006.
   Google Scholar
• Liang C, Qiao JQ, Lian HZ. Determination of reversed-phase high performance liquid chromatography based octanol-water partition coefficients for neutral and ionizable compounds: methodology evaluation. J Chromatogr A. 2017;1528:25–34.
   PubMed Web of Science ®Google Scholar
• Newhouse K, Hsuan SL, Chang SH, Cai BB, Wang YP, Xia ZG. Rotenone-induced apoptosis is mediated by p38 and JNK map kinases in human dopaminergic SH-SY5Y cells. Toxicol Sci. 2004;79(1):137–146.
   PubMed Web of Science ®Google Scholar
• Shutske GM, Pierrat FA, Cornfeldt ML, Szewczak MR, Huger FP, Bores GM, Haroutunian V, Davis KL. (+-)9-amino-1,2,3,4-tetrahydroacridin-1-ol. A potential Alzheimer’s disease therapeutic of low toxicity. J Med Chem. 1988;31(7):1278–1279.
   PubMed Web of Science ®Google Scholar
• Banerjee P, Eckert AO, Schrey AK, Preissner R. Protox-II: a webserver for the prediction of toxicity of chemicals. Nucleic Acids Res. 2018;46(W1):W257–W263.
   PubMed Web of Science ®Google Scholar
• de Felipe KS, Carter BT, Althoff EA, Cornish VW. Correlation between ligand-receptor affinity and the transcription readout in a yeast three-hybrid system. Biochemistry. 2004;43(32):10353–10363.
   PubMed Web of Science ®Google Scholar
• Gallagher SS, Miller LW, Cornish VW. An orthogonal dexamethasone-trimethoprim yeast three-hybrid system. Anal Biochem. 2007;363(1):160–162.
   PubMed Web of Science ®Google Scholar
• Musil K, Florianova V, Bucek P, Dohnal V, Kuca K, Musilek K. Development and validation of a Fia/UV-Vis method for pK(a) determination of oxime based acetylcholinesterase reactivators. J Pharm Biomed Anal. 2016;117(:240–246.
   PubMed Web of Science ®Google Scholar